PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Overview • Comparison by end-user • Pharmaceutical and biotechnology companies • Clinical and reference laboratories • Others • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing availability of add-on software programs • Growing importance of global conferences • Growing use of benchtop automation in industries other than healthcare PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agilent Technologies • Danaher • F. Hoffman-La Roche • PerkinElmer • QIAGEN • Thermo Fisher Scientific • Other prominent vendors PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global laboratory automation market: Segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017-2022 Exhibit 18: Customer landscape Exhibit 19: End-user – Market share 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Pharmaceutical and biotechnology companies– Market size and forecast 2017-2022 ($ mn) Exhibit 22: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%) Exhibit 23: Clinical and reference laboratories – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Clinical and reference laboratories – Year-over-year growth 2018-2022 (%) Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 26: Others – Year-over-year growth 2018-2022 (%) Exhibit 27: Market opportunity by end-user Exhibit 28: Global – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top three countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top three countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top three countries in APAC Exhibit 39: Market opportunity Exhibit 40: Benefits of automation for the healthcare industry Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Vendor overview Exhibit 47: Agilent Technologies – Business segments Exhibit 48: Agilent Technologies – Organizational developments Exhibit 49: Agilent Technologies – Geographic focus Exhibit 50: Agilent Technologies – Segment focus Exhibit 51: Agilent Technologies – Key offerings Exhibit 52: Vendor overview Exhibit 53: Danaher – Business segments Exhibit 54: Danaher – Organizational developments Exhibit 55: Danaher – Geographic focus Exhibit 56: Danaher – Segment focus Exhibit 57: Danaher – Key offerings Exhibit 58: Vendor overview Exhibit 59: F. Hoffman-La Roche – Business segments Exhibit 60: F. Hoffman-La Roche – Organizational developments Exhibit 61: F. Hoffman-La Roche – Geographic focus Exhibit 62: F. Hoffman-La Roche – Segment focus Exhibit 63: F. Hoffman-La Roche – Key offerings Exhibit 64: Vendor overview Exhibit 65: PerkinElmer – Business segments Exhibit 66: PerkinElmer: Organizational developments Exhibit 67: PerkinElmer: Geographic focus Exhibit 68: PerkinElmer: Segment focus Exhibit 69: PerkinElmer: Key offerings Exhibit 70: Vendor overview Exhibit 71: QIAGEN – Business segments Exhibit 72: QIAGEN – Organizational developments Exhibit 73: QIAGEN – Geographic focus Exhibit 74: QIAGEN – Segment focus Exhibit 75: QIAGEN – Key offerings Exhibit 76: Thermo Fisher Scientific: Overview Exhibit 77: Thermo Fisher Scientific: Business segments Exhibit 78: Thermo Fisher Scientific: Organizational developments Exhibit 79: Thermo Fisher Scientific: Geographic focus Exhibit 80: Thermo Fisher Scientific: Segment focus Exhibit 81: Thermo Fisher Scientific: Key offerings

Danaher F. Hoffman-La Roche PerkinElmer QIAGEN Thermo Fisher Scientific